My Doctor Never Warned Me About Depo-Provera's Brain Tumor Risk — And I'm Not Alone

She Asked One Question. Her Doctor Never Answered It.

Maria had been using Depo-Provera for eleven years when she walked into her neurologist's office expecting a routine migraine follow-up. She walked out with a diagnosis she had never heard of: an intracranial meningioma — a brain tumor the size of a grape pressing against her temporal lobe.

Her first call was to her OB-GYN — the doctor who had administered her injections four times a year, without fail, without hesitation. "Did you know this could happen?" she asked. The silence on the line told her what she needed to know.

Maria's story is not unique. It is, in fact, one of thousands now being documented in federal courtrooms across the country. The common thread running through each of them is not just the diagnosis. It is the silence that preceded it.

"I took that shot for over a decade. My doctor never once mentioned the word tumor, never mentioned meningioma, never said 'here are the serious risks you should know about.' I feel like I was denied the right to make a real choice about my own body."

— Composite account reflecting testimony patterns from Depo-Provera meningioma plaintiffs, 2024–2026

What the Science Showed — and When

The link between medroxyprogesterone acetate (MPA) — the active ingredient in Depo-Provera — and meningioma growth is not a recent discovery. Studies flagging the hormonal sensitivity of meningioma cells date back to the 1980s. A landmark French epidemiological study published in 2021 found that women using high-dose progestin contraceptives — including Depo-Provera — had a 5.6-fold increased risk of meningioma requiring surgery compared to non-users.

Despite this, the FDA did not require Pfizer to add a specific meningioma warning to Depo-Provera's label until February 2024 — decades after the underlying biological risk was documented in peer-reviewed literature. Lawsuits allege that Pfizer was aware of this risk much earlier and failed to update its warning label and educate prescribing physicians accordingly.

The gap between what was known and what was communicated to patients — sometimes spanning three or four decades — is the foundation of the legal argument in every active Depo-Provera lawsuit.

The Informed Consent Doctrine: What Your Doctor Was Legally Required to Tell You

In American medicine, the informed consent doctrine is not a courtesy — it is a legal obligation. Before prescribing or administering any medication, a physician must disclose the risks and benefits that a reasonable patient would consider material to their decision. This standard has been upheld in every state.

Applied to Depo-Provera, this means your doctor should have disclosed — at minimum — the following before your first or continuing injection:

A Two-Part Failure: Pfizer and Your Doctor

Lawsuits over Depo-Provera's meningioma risk target two distinct failures that, together, left patients without the information they needed.

Many women are eligible to pursue claims against both Pfizer and their prescribing physician. An attorney can evaluate your specific situation and advise which claims apply.

If You Were Never Warned: What to Do Now

Related Depo-Provera Guides

Frequently Asked Questions